Ascletis Pharma has reported positive topline outcomes from its US Phase Ia SAD study of the oral tablet, ASC30, in obese ...

The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...

Veterinary Pharmaceutical Drug Market Expected To Achieve A Strong 5.07% CAGR, To Reach USD 40.3 Billion By 2032 The rising trend of pet ownership across various regions has significantly impacted the ...